Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-035511
Filing Date
2025-04-16
Accepted
2025-04-16 16:22:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9078
  Complete submission text file 0001104659-25-035511.txt   10598
Mailing Address 18 FIELDSTONE COURT NEW CITY NY 10956
Business Address
Oliveira Steven Michael (Filed by) CIK: 0001358629 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91705 | Film No.: 25843081
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)